Uncover the future of cardiovascular care with ACCEL Lite, an innovative AI-driven approach to screening non-contrast chest CT scans. This groundbreaking technology goes beyond detection, offering precise measurements of critical risk factors like heart calcification, aorta calcification, and fat around the heart. By transforming binary findings into quantifiable data, ACCEL Lite empowers clinicians to identify high-risk patients earlier, potentially preventing heart attacks and strokes. But here's where it gets controversial: while initial studies show promise, larger longitudinal research is needed to understand the long-term impact of quantified imaging markers on cardiovascular health, especially in patients already on preventive therapies like statins and aspirin. In this insightful interview, Deepak L. Bhatt MD, FACC and Tzung-Dau Wang, MD, PhD delve into the details of AI-Enabled Nationwide Opportunistic Screening of Non-Contrast Chest CT for Death and CV Outcomes. Join the conversation and share your thoughts on this cutting-edge technology that could revolutionize cardiovascular care.
